In CRC, 63.4% (n = 52/82) of cancer tissue samples showed EPAS1 copy number amplification, whereas 18.3% (n = 15/82) exhibited EPAS1 DNA deletion when compared to the matched non‐cancer tissues (Figure 2A). This evidence concerns the gene EPAS1 and colorectal carcinoma.